Tuesday 14 October 2025
Saal 2
07.00 – 08.00 AM
Satellite Symposium
08.00 – 09.00 AM
Session 6
Plenary Session
Plenary Session
Chairs: Gil Yosipovitch, USA | Gary Lewin, Germany
08.00 – 08.20 AM
Inflammatory itch, a role for cytokines
Mark Hoon, USA
Mark Hoon, USA
08.20 – 08.40 AM
IgE-independent mast cell activation limits itchscratch reflex to preserve barrier integrity
Thomas Plum, Germany
Thomas Plum, Germany
08.40 – 09.00 AM
Mrgpr Channels in itch: from mouse to man
Xinzhong Dong, USA
Xinzhong Dong, USA
09.00 – 09.45 AM
Session 7
Best of German itch CRCs
Best of German itch CRCs
Chairs: Bernhard Homey, Germany | Ethan Lerner, USA
09.00 – 09.15 AM
Correlation of intra-epidermal nerve-fiber innervation depth with itch intensity in AD
Konstantin Agelopoulos, Germany
Konstantin Agelopoulos, Germany
09.15 - 09.30 AM
Integrated clinical-electrical stimulation and RNA-seq identifies a pruritus-specific gene signature in AD vs psoriasis
Peter Olah, Germany
Peter Olah, Germany
09.30 - 09.45 AM
Somatic symptom disorder: higher pruritus intensity, stress and reduced quality of life in chronic pruritus
Stefan Kahnert, Germany
Stefan Kahnert, Germany
10.30 AM - 12.00 PM
Session 8
Clinics: Role of Psychological factors
Clinics: Role of Psychological factors
Chairs: Laurent Misery, France | Jacek Szepietowski, Poland
10.30 AM - 10.50 AM
Psyche and itch: new clinical and molecular findings
Eva Peters, Germany
Eva Peters, Germany
10.50 - 11.10 AM
Patient acceptance and stigmatization in psoriasis
Adam Reich, Poland
Adam Reich, Poland
11.10 - 11.30 AM
Placebo and nocebo effects in itch
Antoinette Laarhoven, Netherlands
Antoinette Laarhoven, Netherlands
11.30 - 11.50 AM
Itch in different age groups: Relationship with psychological factors
Christina Schut, Germany
Christina Schut, Germany
11.50 AM - 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
Satellite Symposium
01.30 - 01.45 PM
Break
01.45 - 02.45 PM
Session 9
Round table Itch and pain encoding
Round table Itch and pain encoding
Moderators:
Martin Schmelz, Germany | Earl Carstens, USA
Discussants
Ethan Lerner, USA | Matthias Ringkamp, USA | Laurent Misery, France
Martin Schmelz, Germany | Earl Carstens, USA
Discussants
Ethan Lerner, USA | Matthias Ringkamp, USA | Laurent Misery, France
01.45 - 02.05 PM
Specificity vs. pattern specificity of experimental models
02.05 - 02.25 PM
Terminology of chronic itch and pain
02.25 - 02.45 PM
Translation of itch encoding from experimental approaches to the clinics
02.45 - 03.45 PM
Session 10
Clinics
Clinics
Chairs: Christina Schut, Germany | Adam Reich, Poland
02.45 - 03.05 PM
Chronic pruritus in older adults:
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
Epidemiology, associated factors, and impact on quality of life
Juliette Bollemeijer, Netherlands
03.05 - 03.25 PM
Itch in malignancy
Jacek Szepietowski, Poland
Jacek Szepietowski, Poland
03.25 - 03.45 PM
Hematological itch
Madeline Caduc, Germany
Madeline Caduc, Germany
03.45 - 04.15 PM
Break
04.00 - 05.15 PM
Session 11
Chairs: Sonja Ständer, Germany | Elke Weisshaar, Germany
04.15 - 04.35 PM
Future perspectives in basic research of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.35 - 04.55 PM
Future perspectives in treatment of itch
Martin Schmelz, Germany
Martin Schmelz, Germany
04.55 - 05.15 PM
Scratching the surface no more: 20 years of IFSI advancing itch research and treatment
Gil Yosipovitch, USA
Gil Yosipovitch, USA
05.15 - 05.30 PM
Prizes & Closing Ceremony
Forum
09.00 – 09.45 AM
Session 7
Clinics: Best of clinical trials
Clinics: Best of clinical trials
Chairs: Alan Fleischer, USA | Franz Legat, Austria
09.00 – 09.15 AM
Pooled REMIX-1/-2 phase 3 data:
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
Early and sustained symptom improvement with remibrutinib in chronic spontaneous urticaria
Martin Metz, Germany
09.15 – 09.30 AM
Nemolizumab long-term safety and efficacy up to 104 weeks in the ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis
Matthias Augustin, Germany
Matthias Augustin, Germany
09.30 – 09.45 AM
Lebrikizumab provides skin clearance and itch relief at week 16 and week 52: pooled results from 2 phase 3 studies ADvocate1 and ADvocate2
Diamant Thaçi, Germany
Diamant Thaçi, Germany
09.45 – 10.30 AM
Break
10.30 – 12.00 PM
Session 8
Research: Itch mechanisms in inflammatory skin diseases
Research: Itch mechanisms in inflammatory skin diseases
Chairs: Mark Hoon, USA | Manuel Pereira, Germany
10.30 – 10.50 AM
Kappa opioids inhibit spinal circuits to suppress itch
Tayler Sheahan, Germany
Tayler Sheahan, Germany
10.50 – 11.10 AM
Novel findings on IL 31
Bernhard Homey, Germany
Bernhard Homey, Germany
11.10 – 11.30 AM
Parabrachial to central amygdala:
central itch neurons
Darya Pavlenko, USA
central itch neurons
Darya Pavlenko, USA
11.30 – 11.50 AM
Itch mechanism in aged skin
Mitsutoshi Tominaga, Japan
Mitsutoshi Tominaga, Japan
11.50 AM – 12.00 PM
Questions & Answers
12.00 - 12.30 PM
Break
12.30 - 01.30 PM
Satellite Symposium
02.45 - 03.45 PM
Session 10
Clinics
Clinics
Chairs: Simon Müller, Switzerland | Christelle Le Gall-Ianotto, France
02.45 - 03.05 PM
The many faces of itch in India
Asit Mittal, India
Asit Mittal, India
03.05 - 03.25 PM
Itching in Africa
Grace Mulyowa, Uganda
Grace Mulyowa, Uganda
03.25 - 03.45 PM
Itching in keloids and scars
Hong Liang Tey, Singapore
Hong Liang Tey, Singapore